UPDATE 1-Teva Pharm raises full-year profit forecast after solid second quarter By: Reuters: Company News July 31, 2014 at 10:16 AM EDT * Now sees 2014 EPS $4.50-$4.80 with Copaxone competition Read More >> Related Stocks: Teva Pharmaceutical Industries ADR